Oracle Alpha’s Teladoc Health TDOC Stock Holding History

Oracle Alpha’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,581	Closed	-$250K	–	258
2023 Q4	$250K	Buy	+11,581	New	+$214K	0.32%	141

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Oracle Alpha's TDOC Position: Q1 2024 in Review

Oracle Alpha sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 11,581 shares — an estimated $250K sold.

Oracle Alpha first reported a position in TDOC in Q4 2023 and held it in 1 quarter. The position peaked at $250K in Q4 2023. 427 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

Oracle Alpha reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
Oracle Alpha sold 11,581 Teladoc Health shares in Q1 2024, an estimated $250K.
Oracle Alpha first reported a position in Teladoc Health in Q4 2023 and held it in 1 quarter.
Oracle Alpha's Teladoc Health position peaked at $250K in Q4 2023.
427 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Oracle Alpha's 13F filing for Q1 2024, filed 15 May 2024.